Most Recent
Alphapharm says Sanofi patent amendment should doom injunction bid
Generic drug maker Alphapharm is fighting a bid by global pharmaceutical giant Sanofi-Aventis to block the listing of one of its injector pens, saying the proposed injunction should be denied because Sanofi is seeking to amend the patent at issue.
Foxtel should pay more than a gym to stream copyrighted recordings, court told
A Copyright Tribunal decision that led to substantially lower sound recording licence fees for Foxtel was "beyond the pale" because it compared fees charged to the cable TV giant with those charged to fitness centres, the Full Federal Court heard Wednesday.
Rokt’s software innovative but not patentable, IP Australia tells court
An invention that simply puts "a business method or scheme into a computer" is not patentable, the Commissioner of Patents told a court Wednesday on the first day of a highly anticipated trial over a rejected software patent application by marketing tech startup Rokt.
Aristocrat wants tens of millions in pokie IP case
Gaming giant Aristocrat Technologies is seeking damages in the "high tens of millions of dollars" from rival Konami Australia, after the poker machine developer was found liable for patent infringement.
Optus wins appeal of trade mark deregistration
Optus can hang on to its Optus trade mark for marketing and advertising services, after successfully challenging a ruling that the mark should be deregistered for non-use in those areas.